Total Funding
54
58
Total FundingGrant raised
Growth Score
-1 pts
Heat Score
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
115245
OptiKira develops novel therapeutics intended to prevent cell death.
Bradley Backes: Co-FounderPast Role: Abbott, Team Member- Dustin Maly: Co-Founder
About the Company
OptiKira develops novel therapeutics intended to prevent cell death. It targets UPR and regulates its activity to prevent cell degeneration in idiopathic pulmonary fibrosis, nonalcoholic steatohepatitis, diabetes, cancer,, and various neurodegenerative diseases, enabling medical practitioners to treat Retinitis pigmentosa, amyotrophic lateral
sclerosis, and other chronic diseases.
OptiKira was founded in 2014 and is headquartered in Cleveland, Ohio.
